Aphios Corporation is developing enabling technology platforms for improving drug discovery, manufacturing, delivery and pathogenic safety, and enhanced therapeutics for health maintenance, disease prevention and the treatment of certain infectious diseases, cancers and CNS disorders.
Aphios Awarded US Patent Covering Nanoencapsulation of Therapeutic Proteins
Aphios, SAIC-Frederick Sign Subcontract to Develop Nanosomal Formulations for Cancer Treatment
Aphios Secures NIA SBIR Grant to Develop Nanodrug for Alzheimer’s Disease
Aphios Receives U.S. Patent to Formulate Polymer Nanospheres
Jingang Li, Ph.D.
In this interview, AZoNano discusses the development of a novel solid-state optical nanomotor, which is driven by light.
Professor Jacek Jasienak
In this interview, we discuss a nanoparticle ink used to produce low-cost printable perovskite solar cells, helping to catalyze the technology transition toward commercial viable perovskite-based devices.
Ping Wang, Ph.D.
We speak with researchers behind the latest advancement in graphene hBN research that could boost the development of next-generation electronic and quantum devices.
Inoveno’s PE-550 is a best-selling electrospinning/spraying machine that can be used for the continuous production of nanofibers.
The Filmetrics R54 advanced sheet resistance mapping tool for semiconductor and compound semiconductor wafers.
The Filmetrics F40 turns your benchtop microscope into an instrument for measuring thickness and refractive index.